Belimumab After Rituximab in Resistant Primary Juvenile SS

Clinical trial NCT06410833 · RECRUITING

Trial details

NCT number: NCT06410833
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sjogren's Syndrome Pediatric ALL

Start date: 2024-03-09
Primary completion: 2025-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.